Skip to main content

Table 1 The vital signs and basic situation when patients into groups

From: Effect of remimazolam besylate on elderly patients with mechanical ventilation: a single-center randomized controlled study

Project

The control group (mean ± SD)

Experimental group (mean ± SD)

t/Z

P

N = 40

N = 40

age

74.63 ± 8.10

74.80 ± 9.02

0.091

0.928

Gender (male)

23 (57.50%)

27 (67.50%)

0.853

0.356

Heart rate (b/min)

93.95 ± 18.73

99.93 ± 20.18

1.372

0.174

SBP (mmHg)

119.25 ± 33.40

115.45 ± 23.58

0.588

0.558

DBP (mmHg)

73.80 ± 20.80

71.10 ± 16.38

0.645

0.521

Breathing (breaths/min)

18.50 (17.00, 21.00)

19.50 (18.00, 25.00)

2.091

0.037

Temperature (℃)

37.05 (36.70,37.70)

37.10 (36.68, 38.10)

0.554

0.580

APACHE-II

21.75 ± 3.69

22.10 ± 3.87

0.414

0.680

SOFA

13.00 (11.00, 14.75)

13.00 (11.00, 17.00)

0.73

0.465

GCS

11.00 (8.00, 12.00)

11.00 (8.00, 13.00)

0.222

0.824

Past history, n (%)

 COPD

3 (7.50)

5 (12.50)

0.556

0.456

 Heart failure

3 (7.50)

5 (12.50)

0.556

0.456

 Gastrointestinal illness

4 (10.00)

4 (10.00)

0.000

1.000

 Chronic kidney disease

3 (7.50)

3(7.50)

0.000

1.000

 Chronic liver disease

0 (0.00)

3 (7.50)

3.117

0.077

 Cerebrovascular accident

9 (22.50)

5 (12.50)

1.385

0.239

 diabetes

23 (57.50)

22 (55.00)

0.051

0.822

 Coronary heart disease

20 (50.00)

15 (37.50)

1.270

0.260

 hypertension

22 (55.00)

15 (37.50)

2.464

0.116

  1. APACHE II for acute physiology and chronic health evaluation system II score, SOFA Sequential organ failure assessment, GCS Glasgow coma scale, statistical significance was set at P < 0.05